Aha ngwaahịa: Ursodeoxycholic acid ntụ ntụ
Aha ndị ọzọ: nnukwu Ursodeoxycholic acid ntụ ntụ (UDCA)Ursodiol; UDCA; (3a,5b,7b,8x) -3,7-dihydroxycholan-24-oic acid; Ursofalk; Actigall; Urso
CAS Mba:128-13-2
Nyocha: 99% ~ 101%
Agba: Gbanyụọ ọcha ka ọ bụrụ ntụ ntụ edo edo na-acha odo odo
Solubility: soluble na mmiri, kpamkpam soluble na ethyl mmanya
Ọnọdụ GMO: GMO efu
Mbukota: na 25kgs fiber drum
Nchekwa: Debe akpa na-emegheghị n'ebe dị jụụ, ebe kpọrọ nkụ, zere ọkụ siri ike
Ndụ shelf: ọnwa 24 site na ụbọchị mmepụta
Ursodeoxycholic acid ntụ ntụ(CAS 128-13-2) - Ọdịcha ọgwụ na nyocha nyocha
Nchịkọta ngwaahịa
Ursodeoxycholic acid (UDCA), makwaara dị ka Ursodiol, bụ hydrophilic secondary bile acid na ịdị ọcha nke ≥99%. A na-emepụta ya site na cholic acid site na usoro kemịkalụ na usoro enzymatic dị elu, na-eme ka stereoselectivity dị elu na nkwado gburugburu ebe obibi. A na-eji ntụ ntụ kristal na-acha ọcha eme ihe n'ọtụtụ ebe na nyocha ọgwụ na ngwa ọgwụgwọ n'ihi cytoprotective, mgbochi apoptotic, na ihe na-ebelata cholesterol.
Nkọwapụta igodo
- Nọmba CAS: 128-13-2
- Ụdị mkpụrụ ndụ: C₂₄H₄₀O₄
- Arọ Molecular: 392.57 g/mol
- Ebe mgbaze: 203–204°C
- Nchekwa: Chekwaa na -20C n'ebe kpọrọ nkụ, gbara ọchịchịrị.
Usoro nke Omume
UDCA na-arụ ọtụtụ mmetụta ọgwụgwọ:
- Nchedo imeju: na-eme ka mmiri bile dịkwuo mma, na-ebelata saturation cholesterol na bile, na-eme ka akpụkpọ anụ hepatocyte kwụsie ike.
- Mgbochi FATP5: Na-arụ ọrụ dị ka onye na-egbochi protein 5 (FATP5) fatty acid fatty acid, na-emezi metabolism lipid.
- Immunomodulation: Na-egbochi nrụgide oxidative na ụzọ mkpali (dịka, NF-κB, Erk).
- Mgbasa Gallstone: Na-ebelata nnabata cholesterol ma na-agbaze gallstones cholesterol site na nnọchi bile acid.
Ngwa
1. Ọrịa imeju
- Primary Biliary Cholangitis (PBC): Na-eme ka ọkwa enzyme imeju dịkwuo mma (dịka ọmụmaatụ, alkaline phosphatase) ma na-egbu oge ọganihu ọrịa.
- Ọrịa imeju na-adịghị egbu egbu (NAFLD): Na-ebelata mkpokọta lipid imeju.
- Ọrịa Cholestatic: ejiri ya nke ọma na cholestasis intrahepatic nke afọ ime na dose nke 10-25 mg / kg / ụbọchị.
2. Nchịkwa Gallstone
- Dị irè maka cholesterol gallstones na ndị ọrịa na-adịghị mma maka ịwa ahụ.
3. Nnyocha na-apụta
- COVID-19: Ọrụ nwere ike na mbenata okwu nnabata ACE2, na-egbochi ntinye nje.
- Cardioprotection: Achọpụtara maka mgbochi arrhythmic na mgbochi fibrotic mmetụta.
Nchekwa na njikwa
- Okwu egwu: na-ebute mgbakasị anya na anụ ahụ (ụdị 2) .
- Akpachara anya:Ọnọdụ nchịkwa: maka naanị nyocha. Ekwetaghị maka ọgwụgwọ mmadụ ma ọ bụ ọgwụgwọ anụmanụ.
- Jiri ngwa nchedo onwe onye (gloves, goggles).
- Zere iku ume ma ọ bụ kọntaktị ozugbo.
Nkwakọ ngwaahịa na ịtụ
- Ọnụ ọgụgụ dị: 1 g, 10 g, 100 g.
- Nkwakọ ngwaahịa omenala: nnukwu iwu dị mgbe a rịọrọ ya.
- Nnweta COA: Asambodo akọwapụtara nke ọma nyere n'usoro ọ bụla.
Kedu ihe kpatara ịhọrọ ntụ ntụ UDCA anyị?
- Ịdị ọcha dị elu: QC siri ike na-eme ka ≥99% ịdị ọcha site na nyocha HPLC.
- Nkwado nyocha: akwụkwọ nka na ụzụ na usoro njikọ dị.
- Nkwekọrịta zuru ụwa ọnụ: zutere ụkpụrụ ISO na GMP maka ndị n'etiti ọgwụ.
Keywords: Ursodeoxycholic Acid ntụ ntụ, CAS 128-13-2, FATP5 Inhibitor, Cholesterol Gallstones, Nchekwa imeju, ≥99% Ọcha







